97 results
8-K
EX-99.1
VNDA
Vanda Pharmaceuticals Inc
7 Dec 23
Entry into a Material Definitive Agreement
5:19pm
advances in chronic disease, 7(1), 18–33. https://doi.org/10.1177/2040622315617354
Datamonitor Healthcare – Multiple Sclerosis (MS) Patient-Based … Market Forecast published October 2023 and Datamonitor Healthcare – Ulcerative Colitis Patient-Based Market Forecast published March 2023.
About Vanda
8-K
EX-99.1
70wfximlo or4xngk
6 May 20
Vanda Pharmaceuticals Reports First Quarter 2020 Financial Results
4:16pm